EUVIMEDEUVIMED entdecken
Crossref

Mucosal Colonized Engineered Nissle 1917 for Targeted Gut Delivery and Restored Microbiota Homeostasis in Inflammatory Bowel Disease

Hemin Wang, Qing Li, Xianan Zhang, Jing Wang, Bin Li, Yuanfeng Pang, Hanqing Chen, Shenshen Wu, Rui Chen iD

Small · 2026

DOI: 10.1002/smll.202507578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Hemin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Capital Medical University, Beijing, P. R. China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Homeostasis, Gastrointestinal Microbiome, Intestinal Mucosa. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, State Key Program of the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a serious health problem with an increasing disease burden. Oral probiotics are a potential treatment for IBD. However, the limited colonization and lack of sustained activity in the inflamed colon are challenging. In this research, mucosal colonized engineered Nissle 1917 ( EcN ) was designed for targeted gut delivery and restored microbiota homeostasis in IBD. 2‐iminothiolane thiolation was modified on the surface of EcN , thus the employed disulfide bonds can targeted bind with intestinal mucus layer, enhancing EcN activity and retention in the inflamed colon so that the gut microbiota homeostasis can be restored effectively. Further, we developed a probiotic‐based therapeutic platform to load Ononin onto EcN via manganese mineralization (OME). Oral OME can colonize the intestine and deliver drugs to the inflamed colon, exhibiting synergistic targeted drug‐therapeutic effects and restoring macrobiotic homeostasis. Further mechanism study showed that OME ameliorates DSS‐induced intestinal inflammation by upregulating Eubacterium coprostanoligenes, which secretes methylmalonyl‐CoA mutase to modulate intestinal T cell proportions and functional polarization, ultimately restoring immune homeostasis. This research highlighted the potential of mucosal colonized engineered EcN to restore microbiota homeostasis and targeted delivery of drugs, offering a promising strategy for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesHomeostasisGastrointestinal MicrobiomeIntestinal MucosaDrug Delivery SystemsAnimalsProbioticsMiceHumansMice, Inbred C57BL

Stichwörter der Autor:innen

IBD treatmentmicrobiotic homeostasis restoringmineralized drug loadingmucosal colonized nissle 1917targeted drug‐therapeutic

Autor:innen und Institutionen

  • School of Public Health, Capital Medical University, Beijing, P. R. China.
  • Beijing Key Laboratory of environment and aging, Capital Medical University, Beijing, P. R. China.
  • Laboratory for Environmental Health and Allergic Nasal Diseases, Laboratory for Clinical Medicine, Capital Medical University, Beijing, P. R. China.
  • Beijing Laboratory of Allergic Diseases, Capital Medical University, Beijing, P. R. China.
  • Heilongjiang Feihe Dairy Co., Ltd., Beijing, P. R. China.
  • Department of Occupational and Environmental Health, Fourth Military Medical University, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Xi'an, P. R. China.

ORCID-Profile: Rui Chen

Förderung

  • National Science Fund for Distinguished Young Scholars
  • State Key Program of the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Youth Beijing Scholar Program, Beijing Outstanding Young Scientist Program
  • Chinese Institutes for Medical Research, Beijing

Zitieren

APA

Wang, H., Li, Q., Zhang, X., Wang, J., Li, B., Pang, Y., Chen, H., Wu, S., & Chen, R. (2026). Mucosal Colonized Engineered Nissle 1917 for Targeted Gut Delivery and Restored Microbiota Homeostasis in Inflammatory Bowel Disease. Small. https://doi.org/10.1002/smll.202507578

Vancouver

Wang H, Li Q, Zhang X, Wang J, Li B, Pang Y, et al. Mucosal Colonized Engineered Nissle 1917 for Targeted Gut Delivery and Restored Microbiota Homeostasis in Inflammatory Bowel Disease. Small. 2026. doi:10.1002/smll.202507578

BibTeX
@article{Wang2026,
  author = {Wang, Hemin and Li, Qing and Zhang, Xianan and Wang, Jing and Li, Bin and Pang, Yuanfeng and Chen, Hanqing and Wu, Shenshen and Chen, Rui},
  title = {Mucosal Colonized Engineered Nissle 1917 for Targeted Gut Delivery and Restored Microbiota Homeostasis in Inflammatory Bowel Disease},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202507578}
}
Kostenlos starten →